Menu Back toRemaining Challenges to the COVID-19 Response

DIA 2021 Global Annual Meeting

Remaining Challenges to the COVID-19 Response

Session Chair(s)

Mark B. McClellan, MD, PhD

Mark B. McClellan, MD, PhD

  • Director and Robert J. Margolis M.D. Professor of Business, Medicine and Policy
  • Duke-Margolis Center For Health Policy, United States
This forum will continue the discussion of strategies and recommendations from leaders across the healthcare and health policy landscape for collectively addressing the COVID-19 pandemic.
Learning Objective : Describe the roles of vaccines, diagnostics, track and trace practices, and therapeutics in a comprehensive approach to reducing the health and economic impact of the COVID-19 pandemic; Discuss reduction of the COVID-19 disease burden by strategic alignment of regulatory approval and access pathways, increased effectiveness and capacity of clinical trials, management of access to avoid shortages, and real-world data collection to develop evidence on outcomes.


Sissi  Pham, PharmD


Sissi Pham, PharmD

  • Chief Executive Officer
  • AESARA, United States